Literature DB >> 20703514

Inhibition of ATIR by shRNA prevents collagen synthesis in hepatic stellate cells.

Peihong Dong1, Fujun Yu, Xufei Fan, Zhuo Lin, Yongping Chen, Ji Li.   

Abstract

Currently, strategies aimed at disrupting renin-angiotensin-aldosterone system (RAAS) are extensively investigated for treating liver fibrosis. However, the experiment results remain unsatisfactory, mainly due to excessive level of angiotensin II (AngII) in gene expression. In this article, we aim to investigate whether suppression of AngII-type I receptor (ATIR) expression by short hairpin RNA (shRNA) expression vectors decreases the level of collagen synthesis in hepatic stellate cells (HSCs). Three pairs of ATIR-targeted shRNA expression vectors were transfected into HSC-T6 cells. Compared with the control group, both mRNA and protein levels of ATIR expression were significiently decreased in shRNA-treated groups, and the inhibitory effect exhibited a dose- and time-dependent pattern. Accordingly, TGF-β1 mRNA expression in shRNA1 group was reduced by about 54% compared with the control group. The level of Procollagen type III, hyaluronic acid, and laminin declined by about 46.4, 52.6, and 42%, respectively. In conclusion, shRNA expression vectors targeting ATIR could attenuate collagen synthesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20703514     DOI: 10.1007/s11010-010-0542-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  31 in total

1.  Angiotensin II and Aldosterone stimulating NF-kappaB and AP-1 activation in hepatic fibrosis of rat.

Authors:  Xu Li; Ying Meng; Pingsheng Wu; Zhenshu Zhang; Xishan Yang
Journal:  Regul Pept       Date:  2006-09-12

Review 2.  Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.

Authors:  Shyh-Dar Li; Leaf Huang
Journal:  Curr Opin Investig Drugs       Date:  2008-12

Review 3.  The potential of modulating small RNA activity in vivo.

Authors:  Alain van Mil; Pieter A Doevendans; Joost P G Sluijter
Journal:  Mini Rev Med Chem       Date:  2009-02       Impact factor: 3.862

4.  Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage.

Authors:  Paolo Gelosa; Alice Pignieri; Lars Fändriks; Marc de Gasparo; Anders Hallberg; Cristina Banfi; Laura Castiglioni; Lucia Turolo; Uliano Guerrini; Elena Tremoli; Luigi Sironi
Journal:  J Hypertens       Date:  2009-12       Impact factor: 4.844

5.  ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9.

Authors:  Xu Li; Ying Meng; Xi-Shan Yang; Ling-Fei Mi; Shao-Xi Cai
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

Review 6.  The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.

Authors:  Giuseppe Remuzzi; Norberto Perico; Manuel Macia; Piero Ruggenenti
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

Review 7.  Therapeutic potential of RNA interference against cancer.

Authors:  Fumitaka Takeshita; Takahiro Ochiya
Journal:  Cancer Sci       Date:  2006-08       Impact factor: 6.716

8.  Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.

Authors:  Soon Koo Baik; Dong Hun Park; Moon Young Kim; Yeun Jong Choi; Hyun Soo Kim; Dong Ki Lee; Sang Ok Kwon; Young Ju Kim; Joong Wha Park; Sei Jin Chang
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

9.  Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.

Authors:  J J Kuiper; F Boomsma; H van Buren; R de Man; A H J Danser; A H van den Meiracker
Journal:  Eur J Clin Invest       Date:  2008-12       Impact factor: 4.686

Review 10.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

View more
  6 in total

1.  Long non-coding RNAs and hepatocellular carcinoma.

Authors:  Fu-Jun Yu; Jian-Jian Zheng; Pei-Hong Dong; Xiao-Ming Fan
Journal:  Mol Clin Oncol       Date:  2014-09-25

2.  shRNA targeting β1-integrin suppressed proliferative aspects and migratory properties of airway smooth muscle cells.

Authors:  Fei Shi; Chen Qiu; Hui Qi; Wenke Peng
Journal:  Mol Cell Biochem       Date:  2011-10-11       Impact factor: 3.396

Review 3.  Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity.

Authors:  Mary Carmelle Philogene; Tory Johnson; Arthur Jason Vaught; Sammy Zakaria; Neal Fedarko
Journal:  Hum Immunol       Date:  2019-04-19       Impact factor: 2.850

4.  Inhibition of acid-sensing ion channel 1a in hepatic stellate cells attenuates PDGF-induced activation of HSCs through MAPK pathway.

Authors:  Fan-Rong Wu; Chun-Xiao Pan; Chao Rong; Quan Xia; Feng-Lai Yuan; Jie Tang; Xiao-Yu Wang; Nan Wang; Wen-Lin Ni; Fei-Hu Chen
Journal:  Mol Cell Biochem       Date:  2014-06-18       Impact factor: 3.396

Review 5.  Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism.

Authors:  Yong-Ru Liu; Rui-Xue Tang; Wen-Ting Huang; Fang-Hui Ren; Rong-Quan He; Li-Hua Yang; Dian-Zhong Luo; Yi-Wu Dang; Gang Chen
Journal:  World J Hepatol       Date:  2015-12-08

6.  Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis.

Authors:  Ning Zhou; Zhongzhou Si; Ting Li; Guangshun Chen; Zhongqiang Zhang; Haizhi Qi
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.